Blockade of B7-H1 with sPD-1 improves immunity against marine hepatocarcinoma

Anticancer Research

Volumn 25, Issue 5, 2005, Pages 3309-3313

  He, Lanxiang ^a   Zhang, Guimei ^a   He, Yufei ^a   Zhu, Hangang ^a   Zhang, Hui ^a   Feng, Zuohua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

B7 H1; Hepatocarcinoma; Immunotherapy; sPD 1

Indexed keywords

B7 ANTIGEN; B7 H1 ANTIGEN; BETA ACTIN; COMPLEMENTARY DNA; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 4; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOTHERAPY; CELL GROWTH; DENDRITIC CELL; GENE EXPRESSION; GROWTH INHIBITION; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD137; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; ANTIGENS, SURFACE; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; CRICETINAE; DENDRITIC CELLS; INTERFERON TYPE II; INTERLEUKIN-10; LIVER NEOPLASMS, EXPERIMENTAL; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; PEPTIDES; PLASMIDS; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 23344452388     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Mazanet MM and Hughes CC: B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis. J Immunol 169: 3581-3588, 2002.
2. Selenko-Gebauer N, Majdic O, Szekeres A, Hofler G, Guthann E, Korthauer U, Zlabinger G, Steinberger P, Pickl WF, Stockinger H, Knapp W and Stockl J: B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. J Immunol 170: 3637-3644, 2003.
3. Yamazaki T, Akiba H, Iwai H, Matsuda H, Aoki M, Tanno Y, Shin T, Tsuchiya H, Pardoll DM, Okumura K, Azuma M and Yagita H: Expression of programmed death 1 ligands by murine T cells and APC. J Immunol 169: 5538-5545, 2002.
4. Dong HD, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K, Lennon VA, Celis E and Chen LP: Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 8: 793-800, 2002.
5. Curiel TJ, Wei S, Dong H, Alvarez X, Cheng P, Mottram P, Krzysiek R, Knutson KL, Daniel B, Zimmermann MC, David O, Burow M, Gordon A, Dhurandhar N, Myers L, Berggren R, Hemminki A, Alvarez RD, Emilie D, Curiel DT, Chen L and Zou W: Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med 9: 562-567, 2003.
6. Sharma S, Stolina M, Lin Y, Gardner B, Miller PW, Kronenberg M and Dubinett SM: T cell-derived IL-10 promotes lung cancer growth by suppressing both T cell and APC function. J Immunol 163: 5020-5028, 1999.
7. Qin Z, Noffz G, Mohaupt M and Blankenstein T: Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene-modified tumor. J Immunol 159: 770-776, 1997.
8. Haase C, Jorgensen TN and Michelsen BK: Both exogenous and endogenous interleukin-10 affects the maturation of bone-marrow-derived dendritic cells in vitro and strongly influences T-cell priming in vivo. Immunology 107: 489-499, 2002.
9. Dong HD and Chen LP: B7-H1 pathway and its role in the evasion of tumor immunity. J Mol Med 81: 281-287, 2003.
10. Strome SE, Dong HD, Tamura H, Voss SG, Flies DB, Tamada K, Salomao D, Cheville J, Hirano F, Lin W, Kasperbauer J L, Ballman KV and Chen LP: B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma. Cancer Res 63: 6501-6505, 2003.
11. Iwai Y, Ishida M, Tanaka Y, Okazaki T, Honjo T and Minato N: Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc Natl Acad Sci USA 99: 12293-12297, 2002.
12. He YF, Zhang GM, Wang XH, Zhang H, Yuan Y, Li D and Feng ZH: Eukaryotic expression and functional characterization of PD-1 extracellular domain. Chinese Biotechnol 20: 699-703, 2004.
13. He YF, Zhang GM, Wang XH, Zhang H, Yuan Y, Li D and Feng ZH: Blocking programmed death-1 ligand-PD-1 interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue chemokine. J Immunol 173: 4919-4928, 2004.
14. Nishimura H and Honjo T: PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol 22: 265-268, 2001.
15. Zhang X, Schwartz JC, Guo X, Bhatia S, Cao E, Lorenz M, Cammer M, Chen L, Zhang ZY, Edidin MA, Nathenson SG and Almo SC: Structural and functional analysis of the costimulatory receptor programmed death-1. Immunity 20: 337-347, 2004.
16. Carter LL and Carreno BM: Cytotoxic T-lymphocyte antigen-4 and programmed death-1 function as negative regulators of lymphocyte activation. Immunol Res 28: 49-59, 2003.
17. Dong HD, Zhu GF, Tamada K and Chen LP: B7-H1, a third member of the B7 family, co-stimulates T cell proliferation and interleukin-10 secretion. Nat Med 5: 1365-1369, 1999.
18. Tseng SY, Otsuji M, Gorski K, Huang X, Slansky JE, Pai SI, Shalabi A, Shin T, Pardoll DM and Tsuchiya H: B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J Exp Med 193: 839-846, 2001.
19. Ishida M, Iwai Y, Tanaka Y, Okazaki T, Freeman GJ, Minato N and Honjo T: Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues. Immunol Lett 84: 57-62, 2002.
20. Youngnak P, Kozono Y, Kozono H, Iwai H, Otsuki N, Jin H, Omura K, Yagita H, Paradoll DM, Chen LP and Azuma M: Differential binding properties of B7-H1 and B7-DC to programmed death-1. Biochem Biophys Res Commun 307: 672-677, 2003.
21. Wang S, Bajorath J, Flies DB, Dong HD, Honjo T and Chen LP: Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction. J Exp Med 197: 1083-1091, 2003.
22. Shin T, Kennedy G, Gorski K, Tsuchiya H, Koseki H, Azuma M, Yagita H, Chen LP, Powell J, Pardoll D and Housseau F: Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1 receptor. J Exp Med 198: 31-38, 2003.
23. Liu XL, Gao JX, Wen J, Yin LJ, Li O, Zuo T, Gajewski TF, Fu YX, Zheng P and Liu Y: B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism. J Exp Med 197: 1721-1730, 2003.
24. Brown JA, Dorfman DM, Ma FR, Sullivan EL, Munoz O, Wood CR, Greenfield EA and Freeman GJ: Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J Immunol 170: 1257-1266, 2003.
25. Taraban VY, Rowley TF, O'Brien L, Chan HT, Haswell LE, Green MH, Tutt AL, Glennie MJ and Al-Shamkhani A: Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses. Eur J Immunol 32(12): 3617-3627, 2002.